Israel
Middle East · Jerusalem · ILS (Israeli New Shekel)
Economic Snapshot
Population
9.97 million
Israeli Central Bureau of Statistics (CBS) · 2024
GDP
$517 billion
World Bank / IMF · 2024
GDP per Capita
~$51,850
World Bank (derived) · 2024
Healthcare Economics
Health Expenditure (% GDP)
7.3% of GDP (NIS 146 billion / $39.4 billion total health expenditure)
Israeli Central Bureau of Statistics (CBS) · 2024
Health Spending / Capita
$3,941 (below the Western European average of $5,200 and the high-income-country average of $5,930)
Taub Center for Social Policy Studies · 2024
Public Funding Share
National Health Insurance Law mandates universal coverage through 4 competing non-profit HMOs (kupot holim)
Israeli Ministry of Health · 2024
Country Details
Region
Middle East
Capital
Jerusalem
Currency
ILS (Israeli New Shekel)
Timezone
UTC+2 / UTC+3 (IDT)
Languages
Hebrew, Arabic
🚀 Market Opportunities
Israel combines a globally leading medtech innovation ecosystem with a relatively small, sophisticated domestic market — often more valuable as a partnership/co-development and go-to-market testbed than as a large standalone revenue opportunity. The 2024 AMAR reforms explicitly leveraging FDA/EU prior approval are a significant recent development that meaningfully shortens time-to-market for manufacturers already active in those reference markets, and the annual health-basket (sal) process is the single most important strategic milestone for higher-value devices seeking broad national adoption.